Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 2Phase 1 2

Status

Completed 2Terminated 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 5CNS 5Sarcoma 3Head & Neck 3Breast 2Tumor-Agnostic 1Plasma cell 1Genitourinary 1

Conditions

Gliosarcoma 2Glioblastoma 2Sarcoma 1Neoplasms 1Melanoma 1Head and Neck Neoplasms 1Central Nervous System Neoplasms 1

Interventions

Cyclophosphamide 93Doxorubicin 92Radiotherapy 87Temozolomide 69Filgrastim 58Ifosfamide 55Bevacizumab 55Etoposide 48Gemcitabine 44Imatinib Mesylate 43Vincristine 40pembrolizumab 35pazopanib 34Peripheral Blood Stem Cell Transplantation 31Methotrexate 31Nivolumab 30Carboplatin 30fludarabine phosphate 29Irinotecan 29Cisplatin 28Paclitaxel 26Melphalan 26Magnetic Resonance Spectroscopy 26Docetaxel 25Busulfan 25Trabectedin 24apatinib 22Specimen Handling 21Sirolimus 21Antilymphocyte Serum 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × poly ICLC × Sarcoma × Clear all
NCT02423863 2020-12-17

Poly-ICLC

Oncovir, Inc.

Phase 2 Completed
26 enrolled
DermatologicHead & NeckSarcoma

Head and Neck Neoplasms, Melanoma, Neoplasms, Sarcoma

NCT00262730 2019-06-12

Radiation Therapy and Temozolomide Followed by Temozolomide and Poly ICLC in Treating Patients With Newly Diagnosed GBM

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Completed
97 enrolled 11 charts
CNSSarcoma

Glioblastoma, Gliosarcoma

NCT00052715 2018-07-18

Poly-ICLC

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Terminated
31 enrolled 8 charts
CNSSarcoma

Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡